Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study

Giancarlo Agnelli(University of Perugia), Gualberto Gussoni, C. Bianchini(Italfarmaco (Italy)), Melina Verso(University of Perugia), Mario Mandalà(Azienda Ospedaliero Universitaria Ospedali Riuniti), Luigi Cavanna, Sandro Barni(Azienda Ospedaliera Treviglio), Roberto Labianca(Azienda Ospedaliero Universitaria Ospedali Riuniti), Franco Buzzi(Azienda Ospedaliera S.Maria), Giovanni Scambia(Università Cattolica del Sacro Cuore), Rodolfo Passalacqua(Istituti Ospitalieri di Cremona), Sergio Ricci(University of Pisa), Giampietro Gasparini(Ospedale San Filippo Neri), Vito Lorusso(Ospedale Vito Fazzi), Erminio Bonizzoni(University of Milan), Maurizio Tonato
The Lancet Oncology
September 1, 2009
Cited by 598

Abstract


Related Papers

No related papers found

Powered by citation graph analysis